Skip to main content
logo
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
42.43
-2.63 (-5.84%)
At close: Oct 28, 2026, 4:00 PM EDT
42.30
-0.13 (-0.31%)
After-hours: Oct 28, 2026, 7:59 PM EDT

Boston Scientific Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
5,1385,4425,2035,2865,0655,0614,6634,5614,2094,1203,8563,7253,5273,5993,3893,2423,1703,2443,0263,127
Revenue Growth
1.44%7.53%11.58%15.90%20.34%22.84%20.93%22.44%19.34%14.48%13.78%14.90%11.26%10.94%12.00%3.68%8.12%5.43%9.96%15.43%
Gross Profit
3,4163,8363,6013,6723,5303,4103,1963,0862,8922,8412,6372,5672,4152,5292,3382,2182,1802,2222,0592,144
Operating Income
9791,2461,0721,0411,050943937790718799693617609606583526507518482479
Net Income
5829071,3416727557976745654693244955055052613001261742469680
Earnings Per Share
0.400.610.900.450.510.530.450.380.320.220.330.340.340.180.210.090.120.170.070.06
EPS Growth
-21.50%15.09%100.00%18.54%60.00%140.91%36.36%11.98%-6.33%22.22%57.94%285.57%183.33%5.88%210.76%56.67%-57.14%41.67%-70.77%-59.06%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
MedSurg
1,7331,8181,7011,8091,7221,7161,5771,6191,4791,4831,4121,4411,3411,3601,2801,2971,2131,2481,1531,243
Cardiovascular
3,4063,6243,5033,4773,3433,3453,0852,9422,7312,6372,4452,2852,1852,2392,1102,0051,9581,9961,8731,884
Revenue (Total)
5,1385,4425,2035,2865,0655,0614,6634,5614,2094,1203,8563,7253,5273,5993,3893,2423,1703,2443,0263,127

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
5395391,4531,9651,2755347254142,5022,9132,3298659524265709283382763251,925
Total Debt
12,62412,62411,02911,97212,04512,02711,70811,22811,25810,93611,0019,5689,2999,4549,3659,3438,9349,3299,6839,525
Net Cash (Debt)
-12,085-12,085-9,576-10,007-10,770-11,493-10,983-10,814-8,756-8,023-8,672-8,703-8,347-9,028-8,795-8,415-8,596-9,053-9,358-7,600
Net Cash Growth
--------------------
Net Cash Per Share
-8.32-8.19-6.41-6.69-7.20-7.70-7.36-7.26-5.89-5.41-5.85-5.89-5.66-6.20-6.08-5.83-5.97-6.30-6.51-5.29

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-1,4743481,3641,3431,2865411,4561,002813164957698658190807470307-58478
Capital Expenditures
--195-177-351-181-157-187-277-179-155-179-267-190-143-111-212-150-105-121-266
Free Cash Flow
-1,2791711,0131,1621,1293541,179823658-1569050851579595320202-179212
Free Cash Flow Growth
-13.29%-51.70%-14.08%41.19%71.58%-70.87%62.01%27.77%-15.97%58.75%154.95%-180.66%-10.62%-62.38%--58.76%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
66.48%70.49%69.21%69.47%69.69%67.38%68.54%67.66%68.71%68.96%68.39%68.91%68.47%70.27%68.99%68.42%68.77%68.50%68.04%68.56%
Operating Margin
19.05%22.90%20.60%19.69%20.73%18.63%20.09%17.32%17.06%19.39%17.97%16.56%17.27%16.84%17.20%16.23%15.99%15.97%15.93%15.32%
Pretax Margin
14.27%19.48%22.35%13.24%18.52%18.59%17.26%12.80%15.89%10.19%15.79%13.56%17.30%11.84%13.13%12.18%7.73%10.64%5.12%3.87%
Profit Margin
11.33%16.67%25.77%12.71%14.91%15.75%14.45%12.39%11.14%7.86%12.84%13.56%14.32%7.25%8.85%3.89%5.49%7.58%3.17%2.56%
FCF Margin
-23.50%3.29%19.16%22.94%22.31%7.59%25.85%19.55%15.97%-0.39%18.52%14.40%14.31%2.33%18.35%10.10%6.23%-5.92%6.78%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
18.0617.2626.1648.7851.8363.4473.4371.0468.8361.9057.0153.9164.8690.3285.00103.2393.0364.4384.0861.52
Forward PE
13.4312.4318.1128.7131.2836.4135.2533.0832.8032.1830.4426.7625.2526.9726.2124.5120.6720.3625.0123.73
P/FCF Ratio
-17.5026.8438.6437.8345.6049.5149.7757.2461.50-47.2645.5651.5360.1370.6599.9089.85-46.00
PS Ratio
3.003.024.527.047.488.598.507.867.767.446.855.955.625.805.515.234.414.325.215.09